These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 36316117

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England.
    Whittaker H, Rothnie KJ, Quint JK.
    Thorax; 2024 Feb 15; 79(3):202-208. PubMed ID: 37328279
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. COPD exacerbations by disease severity in England.
    Merinopoulou E, Raluy-Callado M, Ramagopalan S, MacLachlan S, Khalid JM.
    Int J Chron Obstruct Pulmon Dis; 2016 Feb 15; 11():697-709. PubMed ID: 27099486
    [Abstract] [Full Text] [Related]

  • 8. Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013.
    Oshagbemi OA, Keene SJ, Driessen JHM, Jordan R, Wouters EFM, de Boer A, de Vries F, Franssen FME.
    Respir Med; 2018 Nov 15; 144():1-6. PubMed ID: 30366578
    [Abstract] [Full Text] [Related]

  • 9. Variability of antibiotic prescribing in patients with chronic obstructive pulmonary disease exacerbations: a cohort study.
    Boggon R, Hubbard R, Smeeth L, Gulliford M, Cassell J, Eaton S, Pirmohamed M, van Staa TP.
    BMC Pulm Med; 2013 May 31; 13():32. PubMed ID: 23724907
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. COPD management costs according to the frequency of COPD exacerbations in UK primary care.
    Punekar YS, Shukla A, Müllerova H.
    Int J Chron Obstruct Pulmon Dis; 2014 May 31; 9():65-73. PubMed ID: 24426781
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. β-Blockers are associated with a reduction in COPD exacerbations.
    Bhatt SP, Wells JM, Kinney GL, Washko GR, Budoff M, Kim YI, Bailey WC, Nath H, Hokanson JE, Silverman EK, Crapo J, Dransfield MT, COPDGene Investigators.
    Thorax; 2016 Jan 31; 71(1):8-14. PubMed ID: 26283710
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and Risk Factors of Respiratory Viral Infections in Exacerbations of Chronic Obstructive Pulmonary Disease.
    Kwak HJ, Park DW, Kim JE, Park MK, Koo GW, Park TS, Moon JY, Kim TH, Sohn JW, Yoon HJ, Shin DH, Kim SH.
    Tohoku J Exp Med; 2016 Oct 31; 240(2):131-139. PubMed ID: 27725531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.